Innovation on Tap

Celebrating founders and CEOs on their entrepreneurial journey

Program

Join your friends and colleagues for a fun fall gathering at the Boxyard@RTP. After the panel, we’ll lift a mug to celebrate Oktoberfest with a selection of seasonal brews and delicious bites from Fullsteam Brewery.

This event is designed for life science startups and founders. Space is limited, so sign up today.

AGENDA:

3:30 – 4:00pm – Registration
4:00 – 5:00pm – Panel
5:00 – 6:30pm – Networking Happy Hour with craft beer and pizza

Panel

Learn from founders and CEOs who recently reached important milestones as they share stories and discuss what’s next as their companies scale.

Speakers

Stephen M. Perry, Founder & CEO, Kymanox
Stephen M. Perry is the CEO and Founder of Kymanox—a diversified and global professional services company solely focused on the Pharmaceutical, Biotechnology, Medical Device, and Combination Product industries. He has extensive CGxP experience as a Process Engineer, Technical Project Manager, Quality Auditor, and Regulatory Strategist. As a business executive, Stephen has successfully attracted growth capital from WestView Capital Partners and has further grown the unique Kymanox platform with the acquisition of four different companies.
Robbie Allen, Co-founder and CEO, Bionic Health
Robbie Allen is a co-founder and CEO at Bionic Health, where he leads strategy, software development, and data science. He’s also Bionic’s first customer. He serves as general partner at Triangle Tweener Fund and is an active angel investor. His previous roles include co-founder, CEO and senior advisor at Infinia ML; and CEO and board member at Automated Insights. He is the author of ten books on technical topics and serves as an advisor and mentor to numerous startups and entrepreneurs.
Nicole Bell, CEO, Galaxy Diagnostics
Leading Galaxy Diagnostics, Nicole Bell is an author, entrepreneur, and advocate for tick-borne and neurodegenerative diseases. She advanced her professional career as an engineer and program manager and spent the past 15 years in medical devices and diagnostics. She became an executive in a fast-growing medical device company, where she built a world-class team in surgical robotics, driving the development of the surgical robot from breadboard design to FDA submission in 3 years, propelling the company’s market cap to over $500M.
Deborah Bitterfield, PhD, Founder and CEO, Lindy Biosciences
Deborah has over 10 years of Pharma/Biotech industry, which reflects positions across a broad range of strategic and operational disciplines including biotherapeutics and medical devices. Prior to launching Lindy Biosciences in 2017, Deborah joined Southeast TechInventures, an innovation lab that partners with university inventors to further develop promising university technologies. Deborah began her career at Duke University in the Program on Values & Ethics in the Marketplace. She holds a PhD in Materials Science from Duke University with a focus in biomaterials.